id-klh vaccine
Vaccineexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 9, 1996 (NCT00001512)
Timeline
Indications
Mechanism of action
- Unspecified targetImmunity, active
immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- id-klh vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00041730 | Phase 2 | Jul 1, 2002 | Favrille |
| NCT00574886 | N/A | Jul 1, 2000 | Genitope Corporation, University of Nebraska |
| NCT00001512 | Phase 1 | Sep 9, 1996 | National Cancer Institute (NCI) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Favrille | For profit | 1 | 1 | 1 | 2002 |
| Genitope Corporation | For profit | 1 | 0 | 1 | 2000 |
| National Cancer Institute (NCI) | Government | 1 | 1 | 1 | 1996 |
| University of Nebraska | Academic/Hospital | 1 | 1 | 1 | 2000 |
4 organizations
Page 1 / 1